Invivyd, Inc. (IVVD)
NASDAQ: IVVD · IEX Real-Time Price · USD
1.320
+0.030 (2.33%)
At close: Jul 26, 2024, 4:00 PM
1.300
-0.020 (-1.52%)
After-hours: Jul 26, 2024, 7:16 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $157.50 million as of July 26, 2024. Its market cap has increased by 7.36% in one year.
Market Cap
157.50M
Enterprise Value
-33.71M
1-Year Change
7.36%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since the IPO on August 6, 2021, Invivyd's market cap has decreased from $1.84B to $157.50M, a decrease of -91.46%. That is a compound annual growth rate of -56.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 153.90M | -64.53% |
| Dec 29, 2023 | 433.90M | 165.38% |
| Dec 30, 2022 | 163.50M | -79.76% |
| Dec 31, 2021 | 807.70M | -56.22% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Repare Therapeutics | 164.69M |
| Stereotaxis | 164.46M |
| INmune Bio | 163.40M |
| Adverum Biotechnologies | 163.36M |
| Galectin Therapeutics | 160.34M |
| Vigil Neuroscience | 159.73M |
| Kodiak Sciences | 158.66M |
| Quipt Home Medical | 157.09M |